Literature DB >> 26469749

Effects of Tauroursodeoxycholic Acid and Alpha-Lipoic-Acid on the Visual Response Properties of Cat Retinal Ganglion Cells: An In Vitro Study.

Huika Xia1, Yan Nan1, Xin Huang1, Jie Gao1, Mingliang Pu1.   

Abstract

PURPOSE: To investigate the effects of tauroursodeoxycholic acid (TUDCA) and alpha-lipoic-acid (ALA) on the visual response properties of cat retinal ganglion cells (RGCs) in wholemount retinas.
METHODS: Young adult cats were divided into three groups: control, ALA, and TUDCA. In vitro single-unit extracellular recordings were performed on wholemount retinas to objectively evaluate the visual response properties of RGCs prior and post to antioxidant treatment. The visual responses properties of RGCs, including receptive field size, luminance threshold, and contrast sensitivity, were collected online and analyzed off-line with Axon Pclamp9.
RESULTS: Most of the RF sizes were larger than those plotted prior to the 60 minutes dark adaptation. The luminance threshold was elevated in the control group (no treatment) but reduced post ALA treatment and significantly reduced post TUDCA treatment. The contrast threshold was significantly elevated in the control group (no treatment) and clearly elevated post ALA treatment but effectively sustained post TUCDA treatment.
CONCLUSIONS: Retinal neurocircuitry deteriorates in wholemount retinas, resulting in abnormal visual response properties in RGCs. Alpha-lipoic-acid and TUDCA exerted beneficial neuroprotective effects by activating the antioxidant pathway, partially restoring the functionality of retinal neurocircuitry and significantly improving the visual response properties of RGCs. However, TUDCA appears to be more effective than ALA in reducing irradiance thresholds and improving contrast sensitivity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26469749     DOI: 10.1167/iovs.15-17301

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

2.  Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases.

Authors:  Alicia Arranz-Romera; Sergio Esteban-Pérez; Irene T Molina-Martínez; Irene Bravo-Osuna; Rocío Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2021-02-27       Impact factor: 4.617

3.  Neuroprotective Effects of Tauroursodeoxicholic Acid Involves Vascular and Glial Changes in Retinitis Pigmentosa Model.

Authors:  Laura Fernández-Sánchez; Henar Albertos-Arranz; Isabel Ortuño-Lizarán; Pedro Lax; Nicolás Cuenca
Journal:  Front Neuroanat       Date:  2022-04-12       Impact factor: 3.543

Review 4.  Bile Acids in Neurodegenerative Disorders.

Authors:  Hayley D Ackerman; Glenn S Gerhard
Journal:  Front Aging Neurosci       Date:  2016-11-22       Impact factor: 5.750

Review 5.  Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease.

Authors:  Alejandra Daruich; Emilie Picard; Jeffrey H Boatright; Francine Behar-Cohen
Journal:  Mol Vis       Date:  2019-10-14       Impact factor: 2.367

6.  Drug Tissue Distribution of TUDCA From a Biodegradable Suprachoroidal Implant versus Intravitreal or Systemic Delivery in the Pig Model.

Authors:  Timothy W Olsen; Roy B Dyer; Fukutaro Mano; Jeffrey H Boatright; Micah A Chrenek; Daniel Paley; Kathy Wabner; Jenn Schmit; Ju Byung Chae; Jana T Sellers; Ravinder J Singh; Timothy S Wiedmann
Journal:  Transl Vis Sci Technol       Date:  2020-05-15       Impact factor: 3.283

7.  Effect of Tauroursodeoxycholic Acid on Inflammation after Ocular Alkali Burn.

Authors:  Yanqiao Huang; Lixia Lin; Yao Yang; Fang Duan; Miner Yuan; Bingsheng Lou; Xiaofeng Lin
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

8.  Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice.

Authors:  Eleni Beli; Yuanqing Yan; Leni Moldovan; Cristiano P Vieira; Ruli Gao; Yaqian Duan; Ram Prasad; Ashay Bhatwadekar; Fletcher A White; Steven D Townsend; Luisa Chan; Caitlin N Ryan; Daniel Morton; Emil G Moldovan; Fang-I Chu; Gavin Y Oudit; Hartmut Derendorf; Luciano Adorini; Xiaoxin X Wang; Carmella Evans-Molina; Raghavendra G Mirmira; Michael E Boulton; Mervin C Yoder; Qiuhong Li; Moshe Levi; Julia V Busik; Maria B Grant
Journal:  Diabetes       Date:  2018-04-30       Impact factor: 9.337

Review 9.  Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.

Authors:  Magdalena Kusaczuk
Journal:  Cells       Date:  2019-11-20       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.